Myovant Sciences Ltd. Operating Cash Flow 2011-2026 | MYOV

Annual Operating Cash Flow Myovant Sciences Ltd.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
371 M	-221 M	-224 M	-117 M	-18.2 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
371 M	-224 M	-42 M

Quarterly Operating Cash Flow Myovant Sciences Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-170 M	-66.9 M	-	-	-168 M	-76.6 M	-	-	464 M	-111 M	-62 M	-	-202 M	-135 M	-66.8 M	-	-171 M	-109 M	-	-	-	-26.6 M	-	-	-7.55 M	-687 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
464 M	-202 M	-60.6 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-57.8 M	-	1052.0 %	$ 415 M	USA
Takeda Pharmaceutical Company Limited TAK	1.01 T	$ 18.06	-	$ 28.2 B	Japan
Amphastar Pharmaceuticals AMPH	156 M	$ 19.44	-0.46 %	$ 909 M	USA
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-18 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-169 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	-15.1 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
I-Mab IMAB	-1.3 B	-	-	$ 866 M	China
Genfit SA GNFT	99.9 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-108 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	-19.4 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-59.7 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Arena Pharmaceuticals ARNA	-452 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	-65.7 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-9.03 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
Atreca BCEL	-80.7 M	-	-11.76 %	$ 5.79 M	USA
Protara Therapeutics TARA	-56.4 M	$ 5.03	-3.08 %	$ 215 M	USA
Acorda Therapeutics ACOR	-14 M	-	-24.86 %	$ 820 K	USA
Tarsus Pharmaceuticals TARS	-12.5 M	$ 67.0	-0.3 %	$ 2.8 B	USA
bluebird bio BLUE	-235 M	-	-	$ 546 M	USA
Acasti Pharma ACST	-14.9 M	-	4.01 %	$ 150 M	Canada
Theravance Biopharma TBPH	239 M	$ 14.9	-1.91 %	$ 750 M	Cayman-islands
Avid Bioservices CDMO	11 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	-92.5 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-30.3 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-29.5 M	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	-206 M	$ 1.2	-6.97 %	$ 306 M	Britain
BeiGene, Ltd. BGNE	1.13 B	-	0.49 %	$ 251 B	Cayman-islands
Bio-Techne Corporation TECH	288 M	$ 51.31	-2.65 %	$ 8.08 B	USA
Tenax Therapeutics TENX	-35.8 M	$ 14.64	-2.2 %	$ 574 M	USA
BioDelivery Sciences International BDSI	41 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-92.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-75.6 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	-13 M	$ 1.07	-2.29 %	$ 21.9 M	Israel
Teva Pharmaceutical Industries Limited TEVA	1.65 B	$ 28.76	-3.43 %	$ 32.9 B	Israel
Enochian Biosciences ENOB	-7.87 M	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	-733 M	-	-	$ 867 M	Germany
Equillium EQ	-22.7 M	$ 2.03	-1.46 %	$ 116 M	USA
Eton Pharmaceuticals ETON	10.5 M	$ 23.81	1.51 %	$ 641 M	USA
Bellerophon Therapeutics BLPH	-17.8 M	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	-345 M	$ 46.38	-2.45 %	$ 4.17 B	Schweiz